(Reuters Health) - The long-term use of aspirin, at low to moderate doses, appears to reduce all causes of mortality in women, especially in older women and those with cardiovascular risk factors, according to the results of a new study. This is primarily due to a reduction in death from cardiovascular disease.
However, an accompanying editorial questions this finding and suggests that, on the basis of previous study findings, women without a history of cardiovascular disease should not start taking aspirin to prevent death.(Read entire article)
Aspirin in low to moderate doses may lower the risk of death in women, particularly those who are older and prone to heart disease, a 24-year study of nearly 80,000 women suggests.
However, experts cautioned that the results are not definitive and that women should not take aspirin as a health preventive without talking to their doctor.
In this long-running study of nurses who were middle-aged and older, women who took aspirin had a 25 percent lower risk of death compared to those who never took it. Aspirin-takers had a 38 percent lower risk of death from cardiovascular disease and a 12 percent lower risk of death from cancer. (Read entire article)